Literature DB >> 3879133

Different gene defects in the salt-wasting (SW), simple virilizing (SV), and nonclassical (NC) types of congenital adrenal hyperplasia (CAH).

D Knorr, E D Albert, F Bidlingmaier, W Höller, S Scholz.   

Abstract

HLA (human leucocyte antigens) alleles and plasma 17-hydroxyprogesterone levels after ACTH stimulation were studied in 134 German families of patients with salt-wasting (SW), simple virilizing (SV), and nonclassical (NC) late-onset forms of CAH. HLA typing revealed a genetic difference between the two classical disease forms. SW-CAH was strongly associated with Bw47 and SV-CAH was closely linked to B5. The nearly complete connection of NC-CAH with B14 was confirmed. Bw47 and B14 were mostly components of the normally rare haplotypes A3, Bw47, DR7 and Aw33, B14, DR1, respectively. They did not occur in the families' disease-unaffected haplotypes. The HLA linkage data were consistent with those obtained from the ACTH stimulation test which showed a higher 17-hydroxyprogesterone increase in the group of genetically defined heterozygous relatives of SW patients than in the groups of heterozygous members of SV and NC families.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879133     DOI: 10.1111/j.1749-6632.1985.tb14592.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Endocrinology and auxology of sibships with non-classical congenital adrenal hyperplasia.

Authors:  F J Cameron; N Tebbutt; J Montalto; A B Yong; M Zacharin; J D Best; G L Warne
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

Review 2.  Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Felix G Riepe; Wolfgang G Sippell
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 3.  The consequences of hyperandrogenism in young women.

Authors:  D R London
Journal:  J R Soc Med       Date:  1987-12       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.